María
Díez Campelo
![Foto de María](/img/uploaded/38c5a6a747cb7a6f7166f9e46294ab84.jpg)
![Foto de University of Oxford](/img/noimage_org.png)
University of Oxford
Oxford, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Oxford (2)
2021
-
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 13, pp. 1426-1436
2020
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151